MYH14 and heart disorder: Recently, small molecule allosteric regulators of myosin have been successfully developed to treat heart disease, suggesting this strategy may be successful for treating other myosin-associated disease conditions (Malik et al., 2011; Green et al., 2016; Alsulami and Marston, 2020).